Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 69539-112

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 69539-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Msn Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azacitidine-carton-label (Azacitidine Carton Label)

Azacitidine-carton-label (Azacitidine Carton Label)
Packaging label for Azacitidine for Injection 100 mg per vial, a lyophilized powder for solution intended for subcutaneous and intravenous use. The label states it is a single-dose vial and a cytotoxic agent. Manufactured by MSN Laboratories Private Limited, India, and distributed by MSN Pharmaceuticals Inc., Piscataway, NJ. Includes NDC 69539-112-01 and storage instructions.*
FDA Label Image

Azacitidine-figure (Azacitidine Figure)

Azacitidine-figure (Azacitidine Figure)
A Kaplan-Meier survival curve graph comparing the proportion surviving over time (months) from randomization between two groups labeled AZA and CCR. The graph includes statistics such as Log-Rank p-value, hazard ratio, and number of deaths. A data table below shows the number at risk at various time points for both groups.*
FDA Label Image

Azacitidine-structure (Azacitidine Structure)

Azacitidine-structure (Azacitidine Structure)
Chemical structure of Azacitidine, depicting the molecular arrangement of its atoms in a standard 2D structural formula format.*
FDA Label Image

Azacitidine-vial-label (Azacitidine Vial Label)

Azacitidine-vial-label (Azacitidine Vial Label)
Label for Azacitidine for Injection 100 mg per vial, a single-dose vial powder for solution. The label indicates use for subcutaneous and intravenous routes, with a caution for cytotoxic agent. Manufactured by MSN Laboratories Private Limited, India, and distributed by MSN Pharmaceuticals Inc., New Jersey. The label includes storage instructions and dosage information reference.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.